<p>(A) Immunohistochemistry for dystrophin induction in TA muscles of adult <i>mdx</i> mice 2 weeks after one single intramuscular injection of 5 µg MOE25(PS), MOE25(PO), MOE20(PS) and 2′OmePS AOs (scale bar = 100 µm). (B) Quantitative evaluation of total dystrophin-positive fibres in TA muscles treated with MOE and 2′OmePS AOs at 2 weeks after a single injection. The data shows that MOE25(PS) AOs restored significantly higher number of dystrophin-positive fibres than those of other AOs and significant difference was observed for all tested AOs compared with untreated <i>mdx</i> control (*p<0.05). (C) RT-PCR to detect exon skipping efficiency at the RNA level demonstrated up to 10% exon 23 skpping in the TA muscle treated with MOE25(PS) AOs...
In Duchenne muscular dystrophy, the exon-skipping approach has obtained proof of concept in animal m...
Antisense-mediated exon skipping, which can restore the reading frame, is a most promising therapeut...
In Duchenne muscular dystrophy, the exon-skipping approach has obtained proof of concept in animal m...
Antisense oligonucleotide (AO)-mediated exon-skipping therapy is one of the most promising therapeut...
Antisense oligonucleotide (AO)–mediated exon-skipping therapy is one of the most promising therapeut...
A promising therapeutic approach for Duchenne muscular dystrophy (DMD) is exon skipping using antise...
Duchenne and Becker muscular dystrophies are allelic disorders arising from mutations in the dystrop...
<p>(A) RT-PCR for detecting exon skipping at the RNA level with treated TA muscles 48 hr after intra...
Background: Systemic delivery of anti-sense oligonucleotides to Duchenne muscular dystrophy (DMD) pa...
BACKGROUND: Systemic delivery of anti-sense oligonucleotides to Duchenne muscular dystrophy (DMD) pa...
<p>(A). The signal intensity of the bands representing mouse dystrophin exon 23 skipping with Vivo-P...
Antisense-mediated exon skipping is a promising approach for the treatment of Duchenne muscular dyst...
Duchenne muscular dystrophy (DMD), the commonest form of muscular dystrophy, is caused by lack of dy...
Antisense oligomer (AO)-mediated splicing manipulation can remove specific exons during transcript p...
Antisense-mediated exon skipping, which can restore the reading frame, is a most promising therapeut...
In Duchenne muscular dystrophy, the exon-skipping approach has obtained proof of concept in animal m...
Antisense-mediated exon skipping, which can restore the reading frame, is a most promising therapeut...
In Duchenne muscular dystrophy, the exon-skipping approach has obtained proof of concept in animal m...
Antisense oligonucleotide (AO)-mediated exon-skipping therapy is one of the most promising therapeut...
Antisense oligonucleotide (AO)–mediated exon-skipping therapy is one of the most promising therapeut...
A promising therapeutic approach for Duchenne muscular dystrophy (DMD) is exon skipping using antise...
Duchenne and Becker muscular dystrophies are allelic disorders arising from mutations in the dystrop...
<p>(A) RT-PCR for detecting exon skipping at the RNA level with treated TA muscles 48 hr after intra...
Background: Systemic delivery of anti-sense oligonucleotides to Duchenne muscular dystrophy (DMD) pa...
BACKGROUND: Systemic delivery of anti-sense oligonucleotides to Duchenne muscular dystrophy (DMD) pa...
<p>(A). The signal intensity of the bands representing mouse dystrophin exon 23 skipping with Vivo-P...
Antisense-mediated exon skipping is a promising approach for the treatment of Duchenne muscular dyst...
Duchenne muscular dystrophy (DMD), the commonest form of muscular dystrophy, is caused by lack of dy...
Antisense oligomer (AO)-mediated splicing manipulation can remove specific exons during transcript p...
Antisense-mediated exon skipping, which can restore the reading frame, is a most promising therapeut...
In Duchenne muscular dystrophy, the exon-skipping approach has obtained proof of concept in animal m...
Antisense-mediated exon skipping, which can restore the reading frame, is a most promising therapeut...
In Duchenne muscular dystrophy, the exon-skipping approach has obtained proof of concept in animal m...